Market revenue in 2023 | USD 50,217.1 million |
Market revenue in 2030 | USD 237,478.4 million |
Growth rate | 24.9% (CAGR from 2023 to 2030) |
Largest segment | Wearable devices |
Fastest growing segment | MHealth |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Wireless Sensor Technology, MHealth, Telehealth, Wearable Devices, Remote Patient Monitoring |
Key market players worldwide | GE HealthCare Technologies Inc Common Stock, AT&T, Athenahealth, Abbott Laboratories, Koninklijke Philips NV, Hill-Rom, Medtronic PLC, OMRON Corp, Fitbit, Garmin Ltd, ResMed Inc, Siren |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to digital patient monitoring devices market will help companies and investors design strategic landscapes.
Wearable devices was the largest segment with a revenue share of 31.3% in 2023. Horizon Databook has segmented the U.S. digital patient monitoring devices market based on wireless sensor technology, mhealth, telehealth, wearable devices, remote patient monitoring covering the revenue growth of each sub-segment from 2018 to 2030.
The U.S. accounted for the largest share in North America due to availability of advanced technologies and recent approval to many digital patient monitoring devices. Manufacturers are investing on R&D to obtain approvals for new products.
For instance, Abbott Laboratories announced FDA approval for the FreeStyle Libre 2 iCGM system for children and adults with diabetes in June 2020. It continuously transmits glucose data every minute and includes customizable, elective real-time alarms to notify consumers when their glucose levels are too low or too high, without the need to scan.
In addition, growth can be attributed to growing geriatric population and increase in penetration of remote patient monitoring devices. Growing prevalence of chronic diseases, such as diabetes, COPD, atherosclerosis, and cancer, also contributes to growth. According to the American Diabetes Association, approximately 34.2 million people in the U.S. were suffering from diabetes in 2018.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. digital patient monitoring devices market , including forecasts for subscribers. This country databook contains high-level insights into U.S. digital patient monitoring devices market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account